In this context, it has been reported that treatment with bevacizumab, a humanized monoclonal antibody against VEGF, decreased the serum VEGF levels and arthritis index (Wang, Da, Li, & Zheng, 2013). This evidence concerns the gene VEGFA and Arthritis.